OTC: CHGCF - Chugai Pharmaceutical Co., Ltd.

六个月盈利: -7.47%
股息率: +2.96%
部门: Healthcare

促销时间表 Chugai Pharmaceutical Co., Ltd.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.

更多详情
It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета jpy
Див.доход ао 3.38
Дивиденд ао 1.13
Сайт https://www.chugai-pharm.co.jp
Цена ао 49.11
每日价格变化: 0% (44.23)
每周价格变化: +1.24% (43.69)
每月价格变化: -14.28% (51.6)
3个月内价格变化: +3.73% (42.64)
六个月内的价格变化: -7.47% (47.8)
每年价格变化: +13% (39.14)
年初以来价格变化: -5.27% (46.69)
所有参数

低估

姓名 意义 年级
P/S 7.8 1
P/BV 5.33 2
P/E 26.64 6
EV/EBITDA 18.38 6
全部的: 5.38

效率

姓名 意义 年级
ROA, % 16.84 5
ROE, % 20.02 7
全部的: 6.33

股息

姓名 意义 年级
Div yield, % 2.96 7.4
DSI 0.9286 9.29
全部的: 6.03

责任

姓名 意义 年级
Debt/EBITDA 0.0301 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 61.96 8
盈利能力 Ebitda, % 113.37 10
盈利能力 EPS, % 106.17 10
全部的: 9.6
更多详情

更多详情



导师 职称 支付 出生年份
Dr. Osamu Okuda President, CEO & Chairman 1.44M 1963 (62 年)
Toshiya Sasai Executive of Investor Relations Group & Corporate Communications Department N/A
Mr. Shinji Hidaka Executive Vice President N/A
Mr. Junichi Ebihara Executive Vice President N/A
Dr. Yoshiaki Ohashi Senior VP & Full-time Audit Supervisory Board Member N/A 1960 (65 年)
Mr. Tetsuya Yamaguchi Executive VP & Head of PHC Solution Unit N/A
Mr. Yoshiyuki Yano Executive Vice President N/A
Mr. Iwaaki Taniguchi Executive VP, Head of Finance Supervisory Division, CFO & Director 1967 (58 年)
Mr. Masayoshi Higuchi VP and Head of Quality, Regulatory Compliance Unit, Business Strategy & Compliance Dept.
Junichi Takano Head of Marketing & Sales Division

地址: Japan, Chuo, 2-1-1 Nihonbashi-Muromachi - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.chugai-pharm.co.jp